Botulinum Toxin Injections Final LCD - Effective February 22, 2026

Date Posted: January 8, 2026

This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV). Responses to comments received may be found as a link at the bottom of the final LCD.

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L35170

LCD Title: Botulinum Toxin Injections

Effective Date: February 22, 2026

Summary of LCD: This Local Coverage Determination (LCD) has been developed to create a policy consistent with current evidence for FDA approved and off-label uses of Botulinum Toxins in the Medicare population.

Visit the Proposed LCDs webpage to access this LCD.

Last Updated Jan 08 , 2026